Genome Web Breaking News
- Fluidigm Shares Rise on Selection of Saliva-Based COVID-19 Assay for Federal Surge Testing
- LumiraDx Gets FDA Emergency Use Authorization for PCR-Based Coronavirus Test
- Coronavirus Testing Specimen Collection Devices From DNA Genotek, Clinical Enterprises Get FDA EUAs
- In Brief This Week: PerkinElmer, Rady Children's Institute for Genomic Medicine, Myriad Genetics, and More
- NIH Kicks Off Second Stage of 4D Nucleome Program With $142M in Research Grants
Stat
- STAT Plus: State treasurers urge Cardinal Health shareholders to reject CEO bonus over opioid crisis
- STAT Plus: Pharmalittle: Fewer Americans are willing to get a Covid-19 shot when it’s first available; remdesivir may not be a big seller
- Opinion: Seeing the Rose Garden superspreader convocation as a ‘never event’
- Opinion: Medicare should break an old rule to let breakthrough digital therapeutics save lives
- For Trump, Covid-19 therapeutics are the new vaccines
NYT science news
Xconomy news
- Sanofi, Pfizer & Bristol Drugs Among the 12 Approvals to Look Out for in Q4
- Vertex Stops Test of Rare Disease Drug, Dimming Pipeline Prospects
- Codiak Bio’s IPO Brings In $82M as Exosome Clinical Trials Begin
- Roche Enlists Dyno to Bring AI to Next-Generation Liver, CNS Gene Therapies
- Despite Phase 2 Failure, Gossamer Bio Sees a Path for Drug in Asthma
Fierce Biotech
- Lab survey illustrates testing delays spreading to non-COVID diagnostic areas
- Intellia to kickstart first single-course ‘curative’ CRISPR shot, as it hopes to beat rivals Alnylam, Ionis and Pfizer
- LabCorp launches COVID-19 antibody test for measuring vaccine effectiveness
- Lilly I-O exec jumps to CAR-T biotech Exuma
- Breast cancer study uncovers new RNA targets for treatment and diagnostics
Fierce Medical Devices
- Lab survey illustrates testing delays spreading to non-COVID diagnostic areas
- LabCorp launches COVID-19 antibody test for measuring vaccine effectiveness
- Owlstone's breath-based biopsy test spots signs of declining liver function
- Genentech taps Stanford University spinout for AI drug discovery partnership
- BARDA taps Beckman Coulter to develop a blood test for MIS-C, the severe childhood illness linked to COVID-19